Analyst Consensus ?
ConsensusBuy29 ratings
Bullish1965.5%
Neutral931.0%
Bearish13.5%
FN2 Earnings Intelligence
Arthur J. Gallagher & Co. (AJG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 7, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 24, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 17, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 4, 2026 |
| UBS | Buy | Buy | Maintain | Aug 3, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 31, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 31, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 11, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Mar 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Dec 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 31, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Oct 10, 2024 |
| TD Cowen | Hold | Hold | Maintain | Aug 13, 2024 |
| Raymond James | Market Perform | Strong Buy | Downgrade | Dec 12, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | May 18, 2021 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jan 11, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jun 18, 2020 |
| CFRA | Hold | Hold | Maintain | May 20, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Aug 1, 2016 |
| William Blair | Market Perform | Underweight | Upgrade | Mar 21, 2016 |
| Sandler O'Neill | Buy | Hold | Upgrade | Apr 10, 2014 |
| Compass Point | Buy | Neutral | Upgrade | Apr 2, 2014 |
| Macquarie | Outperform | Neutral | Upgrade | Jan 28, 2014 |
| Bank of America | Buy | Neutral | Upgrade | Jan 31, 2013 |
Upside is calculated against the persisted current price $259.01. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Elyse Greenspan | $284 | $232.7 | +9.6% | Oct 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $280 | $229.85 | +8.1% | Oct 7, 2026 |
| Mizuho Securities | Analyst unavailable | $271 | $229.85 | +4.6% | Oct 7, 2026 |
| Morgan Stanley | Bob Huang | $260 | $228.91 | +0.4% | Oct 6, 2026 |
| Morgan Stanley | Analyst unavailable | $285 | $227.45 | +10.0% | Sep 25, 2026 |
| Wells Fargo | Elyse Greenspan | $291 | $229.64 | +12.4% | Sep 24, 2026 |
| Mizuho Securities | Analyst unavailable | $292 | $248.04 | +12.7% | Sep 16, 2026 |
| Morgan Stanley | Bob Huang | $290 | $248.36 | +12.0% | Aug 19, 2026 |
| Argus Research | Kevin Heal | $300 | $253.32 | +15.8% | Aug 17, 2026 |
| Morgan Stanley | Analyst unavailable | $270 | $247.3 | +4.2% | Aug 10, 2026 |
| UBS | Analyst unavailable | $299 | $249.42 | +15.4% | Aug 3, 2026 |
| Piper Sandler | Paul Newsome | $287 | $256.46 | +10.8% | Jul 31, 2026 |
| Piper Sandler | Analyst unavailable | $276 | $253.83 | +6.6% | Jul 15, 2026 |
| RBC Capital | Rowland Mayor | $300 | $256.39 | +15.8% | Jul 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $253 | +15.8% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $287 | $256.61 | +10.8% | Jul 9, 2026 |
| UBS | Brian Meredith | $291 | $253.52 | +12.4% | Jul 8, 2026 |
| Barclays | Alex Scott | $292 | $249.77 | +12.7% | Jul 7, 2026 |
| Morgan Stanley | Bob Huang | $255 | $252.44 | -1.5% | Jul 6, 2026 |
| Jefferies | Analyst unavailable | $265 | $220.14 | +2.3% | Jun 11, 2026 |
| UBS | Analyst unavailable | $250 | $212.52 | -3.5% | Jun 8, 2026 |
| UBS | Analyst unavailable | $240 | $203.61 | -7.3% | May 21, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $202.19 | +2.3% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $225 | $216.1 | -13.1% | May 1, 2026 |
| Piper Sandler | Paul Newsome | $211 | $206.4 | -18.5% | May 1, 2026 |
| Mizuho Securities | Analyst unavailable | $259 | $219.12 | -0.0% | Apr 13, 2026 |
| Piper Sandler | Analyst unavailable | $226 | $216.51 | -12.7% | Feb 23, 2026 |
| UBS | Analyst unavailable | $283 | $249.37 | +9.3% | Feb 2, 2026 |
| Truist Financial | Analyst unavailable | $271 | $250.75 | +4.6% | Jan 30, 2026 |
| Piper Sandler | Paul Newsome | $249 | $245.84 | -3.9% | Jan 30, 2026 |
| Wells Fargo | Analyst unavailable | $298 | $245.84 | +15.1% | Jan 30, 2026 |
| Mizuho Securities | Yaron Kinar | $277 | $257 | +6.9% | Jan 14, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $282 | $257 | +8.9% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $311 | $264.84 | +20.1% | Jan 13, 2026 |
| BMO Capital | Michael Zaremski | $275 | $264.84 | +6.2% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $247 | $259 | -4.6% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $292 | $259 | +12.7% | Jan 7, 2026 |
| Piper Sandler | Analyst unavailable | $272 | $262.77 | +5.0% | Jan 7, 2026 |
| Wells Fargo | Analyst unavailable | $328 | $253.39 | +26.6% | Dec 22, 2025 |
| Morgan Stanley | Analyst unavailable | $300 | $252.64 | +15.8% | Dec 19, 2025 |
| Needham | Analyst unavailable | $272 | $251.52 | +5.0% | Dec 18, 2025 |
| UBS | Brian Meredith | $285 | $251.98 | +10.0% | Dec 17, 2025 |
| Goldman Sachs | Analyst unavailable | $293 | $252.12 | +13.1% | Dec 17, 2025 |
| Wolfe Research | Tracy Benguigui | $289 | $251.98 | +11.6% | Dec 17, 2025 |
| Evercore ISI | David Motemaden | $334 | $251.98 | +29.0% | Dec 17, 2025 |
| Truist Financial | Analyst unavailable | $280 | $251.38 | +8.1% | Dec 16, 2025 |
| Mizuho Securities | Yaron Kinar | $276 | $256.19 | +6.6% | Dec 15, 2025 |
| Piper Sandler | Analyst unavailable | $280 | $255.46 | +8.1% | Dec 15, 2025 |
| Wells Fargo | Elyse Greenspan | $344 | $245.41 | +32.8% | Dec 5, 2025 |
| Barclays | Analyst unavailable | $250 | $248.72 | -3.5% | Nov 20, 2025 |
| Piper Sandler | Paul Newsome | $295 | $246.23 | +13.9% | Oct 31, 2025 |
| Goldman Sachs | Robert Cox | $315 | $244.82 | +21.6% | Oct 31, 2025 |
| Evercore ISI | David Motemaden | $353 | $262.03 | +36.3% | Oct 31, 2025 |
| Piper Sandler | Paul Newsome | $340 | $305.84 | +31.3% | Oct 2, 2025 |
| UBS | Analyst unavailable | $329 | $297.91 | +27.0% | Sep 19, 2025 |
| Wells Fargo | Analyst unavailable | $365 | $297.91 | +40.9% | Sep 19, 2025 |
| Truist Financial | Mark Hughes | $290 | $301.82 | +12.0% | Jan 31, 2025 |
| Goldman Sachs | Robert Cox | $313 | $304.29 | +20.8% | Nov 25, 2024 |
| BMO Capital | Michael Zaremski | $325 | $281.45 | +25.5% | Nov 12, 2024 |
| Bank of America Securities | Joshua Shanker | $293 | $294.94 | +13.1% | Oct 10, 2024 |
| Jefferies | Yaron Kinar | $274 | $293.16 | +5.8% | Oct 9, 2024 |
| Goldman Sachs | Robert Cox | $300 | $279.45 | +15.8% | Sep 27, 2024 |
| RBC Capital | Scott Heleniak | $320 | $282.2 | +23.5% | Sep 20, 2024 |
| Barclays | Alex Scott | $300 | $297.75 | +15.8% | Sep 4, 2024 |
| CFRA | Catherine Seifert | $320 | $283.58 | +23.5% | Jul 26, 2024 |
| Truist Financial | Mark Hughes | $265 | $282.14 | +2.3% | Jul 26, 2024 |
| RBC Capital | Scott Heleniak | $310 | $280.9 | +19.7% | Jul 26, 2024 |
| Piper Sandler | Paul Newsome | $254 | $273.97 | -1.9% | Jul 26, 2024 |
| RBC Capital | Scott Heleniak | $290 | $254.52 | +12.0% | Jun 26, 2024 |
| Argus Research | John Staszak | $270 | $249.5 | +4.2% | May 14, 2024 |
| Piper Sandler | Paul Newsome | $252 | $234.21 | -2.7% | Apr 29, 2024 |
| Truist Financial | Mark Hughes | $255 | $244.13 | -1.5% | Apr 10, 2024 |
| Citigroup | Analyst unavailable | $228 | $196.32 | -12.0% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $215 | $190.17 | -17.0% | Dec 29, 2022 |
| Citigroup | Analyst unavailable | $225 | $193.11 | -13.1% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $204 | $196.28 | -21.2% | Nov 22, 2022 |
| Jefferies | Yaron Kinar | $211 | $158.74 | -18.5% | Jun 23, 2022 |
| Raymond James | Analyst unavailable | $195 | $168.49 | -24.7% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $211 | $179.33 | -18.5% | Apr 29, 2022 |
| UBS | Weston Bloomer | $192 | $179.5 | -25.9% | Apr 20, 2022 |
| Truist Financial | Mark Hughes | $205 | $183.22 | -20.9% | Apr 11, 2022 |
| Bank of America Securities | Joshua Shanker | $151 | $166.64 | -41.7% | Oct 29, 2021 |
| Deutsche Bank | Phil Stefano | $145 | $137.99 | -44.0% | Jul 30, 2021 |
Track every rating change on AJG the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.